Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology

Targeted genome editing is a continually evolving technology employing programmable nucleases to specifically change, insert, or remove a genomic sequence of interest. These advanced molecular tools include meganucleases, zinc finger nucleases, transcription activator-like effector nucleases and RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Eksi, Yunus E, Sanlioglu, Ahter D, Akkaya, Bahar, Ozturk, Bilge Esin, Sanlioglu, Salih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246254/
https://www.ncbi.nlm.nih.gov/pubmed/34249224
http://dx.doi.org/10.4252/wjsc.v13.i6.485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246254/
https://www.ncbi.nlm.nih.gov/pubmed/34249224
http://dx.doi.org/10.4252/wjsc.v13.i6.485

Ejemplares similares